Projects funded by the NCN
Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system disorders with the focus on neuropathic pain
2020/36/C/NZ7/00284
Keywords:
histamine H3 receptors sigma-1 receptors neuropathic pain polypharmacology
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: SONATINA 4 - announced on 2019-12-16
Amount awarded: 1 081 987 PLN
Project start date (Y-m-d): 2020-09-10
Project end date (Y-m-d): 2023-09-09
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.